Hjem › Nevroendokrine tumorer › Missouri › St. Louis
Kliniske studier for Nevroendokrine tumorer i St. Louis, MO
7 studier for Nevroendokrine tumorer søker deltakere på steder i og rundt St. Louis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RekruttererFase 2/3
- Siteman Cancer Center, St Louis
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RekruttererFase 1
- Research Facility, St Louis
- Research Facility, St Louis
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Cardinal Glennon Children's Medical Center, St Louis
- Washington University School of Medicine, St Louis
- Mercy Hospital Saint Louis, St Louis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruttererFase 1/2
- Washington University Infusion Center Pharmacy, St Louis
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RekruttererFase 1/2
- Washington University, St Louis
Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)
RekruttererFase 2
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, St Louis
Nevroendokrine tumorer-studier i andre byer
- Philadelphia, PA11 studier
- Washington, DC11 studier
- Rochester, MN9 studier
- Houston, TX8 studier
- Chicago, IL7 studier
- Columbus, OH7 studier
- Detroit, MI7 studier
- Salt Lake City, UT7 studier
- Cleveland, OH7 studier
- Dallas, TX6 studier
- Charlottesville, VA6 studier
- Miami, FL6 studier
Andre studier i St. Louis
- Ikke-småcellet lungekreft73 studier
- Brystkreft64 studier
- Metastatisk kreft54 studier
- Kolorektal kreft50 studier
- Kreft (alle typer)46 studier
- Prostatakreft46 studier
- Lungekreft39 studier
- Eggstokkreft38 studier
- Pankreaskreft33 studier
- Endometriekreft29 studier
- Plateepitelcancer i hode og hals28 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.